Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR8G2 Inhibitors

OR8G2, a member of the olfactory receptor family of genes, plays a vital role in the detection of odorants in the olfactory system of organisms. This gene encodes a protein that is part of the G-protein coupled receptor (GPCR) superfamily, which is essential for olfactory signal transduction. The expression of OR8G2, like other genes, is subject to sophisticated regulatory mechanisms that ensure the appropriate cellular and temporal production of its protein product. The regulation of gene expression is a highly orchestrated process involving multiple levels of control, including epigenetic modifications, transcription factor binding, mRNA stability, and translational control. Understanding the intricate controls of OR8G2 expression is crucial for elucidating the complex nature of olfactory perception and the specificity of odorant detection. A selection of chemical compounds has been identified that could potentially inhibit the expression of the OR8G2 protein. These compounds operate through various mechanisms to decrease the production or availability of the OR8G2 protein. For instance, histone deacetylase inhibitors like Trichostatin A can alter chromatin structure, potentially leading to the downregulation of OR8G2 transcription. DNA intercalating agents and transcriptional inhibitors, such as Actinomycin D, directly block the transcriptional machinery, thereby reducing OR8G2 mRNA levels. Translation inhibitors like Cycloheximide can prevent the synthesis of OR8G2 protein by stalling mRNA translation. In addition, certain small-molecule inhibitors can indirectly lead to decreased expression of OR8G2 by targeting intracellular signaling pathways. Examples include PD98059, which inhibits the MEK1/ERK pathway, and LY294002, which acts on the PI3K/Akt pathway, both of which are involved in the control of gene expression. The use of these compounds provides valuable tools to dissect the regulatory networks that control OR8G2 expression and to enhance our understanding of the genetic control of olfactory systems.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Trichostatin A, a histone deacetylase inhibitor, can lead to hyperacetylation of histones near the OR8G2 gene, potentially resulting in a downregulation of OR8G2 transcription as the acetylated chromatin state often correlates with gene silencing for certain olfactory receptor genes.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase, 5-Azacytidine could decrease methylation levels at the OR8G2 gene locus, which may paradoxically lead to gene repression through demethylation-induced reorganization of chromatin structure.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D binds to DNA at the transcription initiation complex and blocks RNA polymerase movement, which would halt OR8G2 gene transcription, thereby decreasing OR8G2 mRNA levels and subsequent protein synthesis.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin targets RNA polymerase II, the enzyme responsible for mRNA synthesis, and its inhibitory action would directly lead to a reduction in OR8G2 mRNA transcript levels.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin (Sirolimus) binds to FKBP12 and inhibits mTOR, a critical kinase for cell growth and proliferation; this action could suppress transcription factors or coactivators needed for OR8G2 expression.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide, by inhibiting the translocation step in protein synthesis, would result in a decreased level of OR8G2 protein, assuming OR8G2 mRNA is being translated.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD 98059, by inhibiting MEK1, leads to a decrease in ERK phosphorylation, which could downregulate transcription factors responsible for OR8G2 gene expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002, by inhibiting PI3K, could decrease Akt activity, leading to reduced transcriptional activity of factors that promote OR8G2 expression.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$108.00
$245.00
$918.00
$49.00
33
(2)

Quercetin, a flavonoid with antioxidant properties, could downregulate OR8G2 expression by attenuating the activity of transcription factors or by altering gene promoter methylation specifically associated with the OR8G2 gene.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin has been reported to downregulate the expression of various genes by inhibiting NF-κB signaling; this could extend to OR8G2 if NF-κB is involved in its gene regulation.